World Pancreatic Cancer Day: Addenbrooke’s patient opens up about healing power of nature after pancreatic cancer diagnosis
An Addenbrooke’s cancer patient says the healing power of nature, and going for daily walks around the Colleges of the University of Cambridge are helping him live with stage four pancreatic cancer.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
High accuracy sample positioner now offers up to 800 µm travel
Queensgate’s NanoScan SP800 nanopositioning sample scanner offers high-accuracy positioning performance for longer ranges.
Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria
Prediabetes: tips for preventing diabetes and improving health
14 of November is World Diabetes Day. It is estimated that 422 million people around the world are living with diabetes.
Invisible hearing aids “a first for Cambridgeshire”
Discover the future of hearing care at angli-EAR Hearing in Great Shelford. We're proud to be the first audiology clinic in Cambridgeshire offering Phonak Lyric, a revolutionary 100% invisible hearing aid. Unlike traditional devices, Lyric sits deep inside the ear canal for complete invisibility, worn 24/7 for months. Lead Audiologist Trevor Chapman explains the benefits, including relief from…
NHS green champions help tackle the climate emergency
A team of green champions at Addenbrooke’s and the Rosie have been inspiring colleagues to take simple steps to help protect the planet.
1 in 10 go free in November at Hilton Cambridge City Centre
PLANNING YOUR LAST MEETING FOR THE YEAR? 1 IN 10 GO FREE IN NOVEMBER AS OUR GIFT TO YOU
A longitudinal perspective on innovation
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property.
Record year for Alzheimer’s Research UK as it achieves £50m income milestone during groundbreaking year
Alzheimer’s Research UK’s income has reached £50m for the first time, during a year marked by historic breakthroughs in dementia research.
Expand your horizons: think big with a Cleanroom Solutions turnkey project
Let the Guardtech Group heritage business take away the hassle of building the large-scale facility of your dreams
NanoSyrinx appoints Anthony Johnson as Non-Executive Director
Appointment of Big Pharma executive strengthens leadership team to drive ambitious growth strategy
Get to know the Governance and Ethics team at the NIHR BioResource
Who are they, what a day looks like in the team and everything involved in making our Governance and Ethics team one of the key resources as part of the NIHR BioResource!
Snakes and Ladders - navigating your investment journey
A workshop for tech founders and directors who are new to the investment journey.
Strong growth trajectory for AstraZeneca as it reports 9M and Q3 2023 results
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said:
“Our company continued its strong growth trajectory in the third quarter with Total Revenue from our non‑COVID-19 medicines up 13% compared to last year.
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future competito
Yourgene Health and Laboriad launch non-invasive prenatal testing in Morocco
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents
How safe will driverless car technology be by 2025?
The government aims to have driverless, or autonomous, cars on the road by 2025.
The burden of non-specific pain disorder in US women
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and healthcare
Neurosurgeon Hutch lands top research award
A Cambridge University Hospital’s expert has won an award often described as the “Nobel Prize of Neurosurgery”.
Lario Therapeutics receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies
CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical” presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London First-in-class ion channel inhibitors show promise as anti-seizure therapeutics f
Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer
Cambridge, UK - Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, announces the appointment of Hazel Jones as Chief Operating Officer.
Polygenic scores: why one size does not fit all - podcast and new briefings
Opinions on whether polygenic scores should be used in health care - imminently or in the longer term - seem to be divided, with stakeholders, at least in the public domain, tending to one side or the other.